Latest News
Conference Coverage
Treatment of basal cell carcinoma with 1064-nm Nd:YAG laser promising
DALLAS – At the 1-year follow-up, there have been no recurrences in the 11 treated patients, as determined by clinical observation.
Conference Coverage
Early results favor combo IL-15/anti-CD20 in indolent NHL
CHICAGO – The researchers tested the combination of rituximab with the IL-15 receptor super agonist complex ALT-803.
Conference Coverage
Novel, noninvasive skin cancer detection device shows promise
DALLAS – The investigational device is based on laser spectroscopy and machine-learning algorithms.
News
Novartis CAR T-cell therapy adds a lymphoma indication
The new approval puts tisagenlecleucel head to head with Gilead’s axicabtagene ciloleucel.
Conference Coverage
NHLBI seeks to accelerate hemostasis/thrombosis research
SAN DIEGO – About half of hemostasis/thrombosis research is basic in nature.
Daily News Podcast
MDedge Daily News: Fewer smokes mean fewer strokes
And is your EHR preventing breastfeeding?
Conference Coverage
Simplified HCT-CI better predicts outcomes in young patients
NEWPORT BEACH, CALIF. – A revised HCT-CI for adolescents and young adults is useful for predicting nonrelapse mortality in this specific...
Feature
Five-year survival for non-Hodgkin lymphoma tops 71%
The most advanced cases are the most likely to be diagnosed.
Conference Coverage
Does warfarin cause acute kidney injury?
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
Daily News Podcast
MDedge Daily News: Is ‘medical aid in dying’ suicide?
And one in five Medicaid kids may have a mental health diagnosis.
News
FDA begins priority review of cemiplimab for advanced cutaneous squamous cell carcinoma
Cemiplimab targets the checkpoint inhibitor PD-1.